Inj monocef
Reading File
Finding Sources
Searching the Web
Inj Monocef ceftriaxone uses dose indications
Finding Sources
Reading File
Reading File
Here is a complete clinical profile of Inj Monocef (Ceftriaxone):
Inj Monocef (Ceftriaxone)
Class: Third-generation cephalosporin (beta-lactam antibiotic)
Brand: Monocef (also sold as Rocephin, Oframax, etc.)
Available as: 250 mg, 500 mg, 1 g, 2 g powder for injection (IV/IM)
Mechanism of Action
Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing cross-linking of peptidoglycan chains. It is bactericidal and resistant to many narrow-spectrum beta-lactamases. However, it is hydrolyzed by ESBL (extended-spectrum beta-lactamases) and KPC-type carbapenemases.
Antimicrobial Spectrum
Gram-positive (good activity):
- Streptococcus pneumoniae, other streptococci
- MSSA (limited; inferior to 1st-gen cephalosporins)
- NOT active against MRSA, Enterococcus
Gram-negative (excellent activity):
- Haemophilus influenzae, Neisseria gonorrhoeae, N. meningitidis
- E. coli, Klebsiella, Proteus, Salmonella, Citrobacter, Serratia, Providencia
- NOT reliably active against Pseudomonas aeruginosa (use ceftazidime or carbapenems)
Anaerobes: Poor activity against Bacteroides fragilis
- Katzung's Basic and Clinical Pharmacology, 16th Ed.
- Goodman & Gilman's Pharmacological Basis of Therapeutics
Pharmacokinetics
| Parameter | Value |
|---|---|
| Half-life | ~7-8 hours (longest among 3rd-gen cephalosporins) |
| Protein binding | ~85-95% |
| CSF penetration | Yes - adequate for meningitis treatment |
| Excretion | ~50% biliary (feces), ~50% renal |
| Renal dose adjustment | NOT required (biliary excretion compensates) |
The long half-life allows once-daily dosing for most indications - a key advantage over other 3rd-gen agents.
Dosing (Adults)
| Indication | Dose | Frequency |
|---|---|---|
| Most serious infections | 1-2 g IV/IM | Once daily |
| Meningitis | 2 g IV | Every 12 hours |
| Endocarditis / Osteomyelitis | 2 g IV | Every 24 hours |
| Gonorrhea (uncomplicated) | 500 mg IM | Single dose |
| Surgical prophylaxis | 1 g IV | 30-120 min before surgery |
| Maximum daily dose | 4 g | - |
Pediatric dosing: 50-100 mg/kg/day (max 2 g for non-meningitis; max 4 g for meningitis)
Clinical Indications
- Meningitis - drug of choice for bacterial meningitis caused by N. meningitidis, H. influenzae, susceptible S. pneumoniae
- Community-acquired pneumonia (severe/hospitalized)
- Sepsis (empiric broad-spectrum cover)
- Gonorrhea - IM single dose is the regimen of choice for gonococcal infections
- Typhoid fever - 2 g/day IV for 7-14 days
- Pyelonephritis / UTI - empiric parenteral therapy
- Intra-abdominal infections (often combined with metronidazole for anaerobic cover)
- Lyme disease (IV ceftriaxone for CNS/cardiac involvement)
- Skin and soft tissue infections
- Bone and joint infections (osteomyelitis, septic arthritis)
- Perioperative surgical prophylaxis
- Neonatal ophthalmia prophylaxis (gonococcal)
Adverse Effects
- GI: Diarrhea, nausea, C. difficile colitis (pseudomembranous colitis)
- Hypersensitivity: Rash, urticaria, anaphylaxis (cross-reactivity with penicillins ~1-2%)
- Biliary sludge/pseudolithiasis - ceftriaxone can precipitate in bile (especially in children receiving high doses); usually reversible
- Hematologic: Eosinophilia, thrombocytopenia, hemolytic anemia (rare)
- Injection site reactions (pain with IM injection - use lidocaine as diluent to reduce pain)
Important Contraindications / Precautions
- Hypercalcemia or IV calcium-containing solutions in neonates - FATAL precipitation of ceftriaxone-calcium can occur in lungs and kidneys; do NOT co-administer with calcium-containing IV solutions (including TPN) in neonates
- Hypersensitivity to cephalosporins or severe penicillin allergy
- Neonates with jaundice - ceftriaxone displaces bilirubin from albumin, worsening hyperbilirubinemia
Reconstitution / Administration
- IV: Dissolve in Water for Injection; dilute in 100 mL NS or D5W; infuse over 30 minutes
- IM: Reconstitute with 1% lidocaine (without epinephrine) to reduce pain
- Do NOT mix with calcium-containing solutions (Ringer's lactate, Hartmann's)
- Compatible with: 0.9% NaCl, 5% Dextrose
Key Clinical Pearls
- No renal dose adjustment needed (biliary excretion takes over) - safe in renal failure
- Avoid in neonates if IV calcium is being given concurrently
- IM ceftriaxone is the standard of care for uncomplicated gonorrhea
- If ESBL-producing organisms are suspected, switch to a carbapenem
- For meningitis - divide dose to 2 g every 12 h for better CNS exposure
Inj monocef according to weight
Finding Sources
Searching the Web
ceftriaxone weight based dosing pediatric adult mg/kg chart
Finding Sources
Reading Web Page
https://reference.medscape.com/drug/ceftriaxone-342510
Here is the complete weight-based dosing guide for Inj Monocef (Ceftriaxone):
Inj Monocef (Ceftriaxone) - Weight-Based Dosing
PEDIATRIC DOSING (weight-based)
General Rule: 50-100 mg/kg/day (Max 4 g/day)
| Weight | General Infections (50 mg/kg) | Serious Infections (75 mg/kg) | Meningitis (100 mg/kg) |
|---|---|---|---|
| 5 kg | 250 mg/day | 375 mg/day | 500 mg/day |
| 8 kg | 400 mg/day | 600 mg/day | 800 mg/day |
| 10 kg | 500 mg/day | 750 mg/day | 1 g/day |
| 12 kg | 600 mg/day | 900 mg/day | 1.2 g/day |
| 15 kg | 750 mg/day | 1.1 g/day | 1.5 g/day |
| 18 kg | 900 mg/day | 1.35 g/day | 1.8 g/day |
| 20 kg | 1 g/day | 1.5 g/day | 2 g/day |
| 25 kg | 1.25 g/day | 1.875 g/day | 2.5 g/day |
| 30 kg | 1.5 g/day | 2.25 g/day | 3 g/day |
| 35 kg | 1.75 g/day | 2.6 g/day | 3.5 g/day |
| 40 kg | 2 g/day | 3 g/day | 4 g/day (max reached) |
| ≥40 kg | Use adult dose |
ADULT DOSING (fixed dose, not weight-based)
| Condition | Dose | Frequency |
|---|---|---|
| General infections | 1-2 g | Once daily |
| Meningitis | 2 g | Every 12 hours |
| Endocarditis / Osteomyelitis | 2 g | Once daily (2-6 weeks) |
| Uncomplicated gonorrhea | 500 mg IM | Single dose |
| Obesity (≥150 kg) | 1000 mg IM | Single dose (for gonorrhea) |
| Surgical prophylaxis | 1 g IV | 30-120 min before surgery |
| Max dose | 4 g/day | - |
SPECIAL INDICATIONS (Pediatric - mg/kg)
| Indication | Dose | Notes |
|---|---|---|
| Acute otitis media | 50 mg/kg IM | Single dose; max 1 g |
| Otitis media (persistent/failure) | 50 mg/kg | Once daily x 3 days |
| Meningitis | 100 mg/kg/day | Divided q12h; max 4 g/day |
| Serious infections | 50-75 mg/kg/day | Divided q12h; max 2 g/day |
| Gonorrhea (neonates) | 25-50 mg/kg IV/IM | Single dose; max 125 mg |
| Epiglottitis | 100 mg/kg on day 1, then 50-75 mg/kg | 10-14 days |
NEONATAL DOSING
| Age | Dose | Frequency |
|---|---|---|
| 0-28 days | 20-50 mg/kg/day | Once daily |
| >28 days | 50 mg/kg/day | Once daily |
Warning: Do NOT give ceftriaxone to neonates receiving IV calcium (including TPN) - risk of fatal calcium-ceftriaxone precipitation in lungs/kidneys.
KEY RULES TO REMEMBER
- Once child reaches 40-50 kg - use adult fixed dose (1-2 g/day)
- No renal dose adjustment needed (biliary excretion compensates) - safe in renal failure
- Hepatic impairment - use with caution if combined with severe renal impairment
- For meningitis - always divide into 2 doses (q12h) for better CSF penetration
- For IM injection - reconstitute with 1% lidocaine to reduce pain
This is a shared conversation. Sign in to Orris to start your own chat.